Ignite Creation Date:
2024-05-06 @ 7:27 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06012734
Status:
RECRUITING
Last Update Posted:
2023-09-05
First Post:
2023-07-21
Brief Title:
LB-100 PP2A Inhibitor and Atezolizumab PD-L1 Inhibitor in Metastatic Colorectal Cancer Patients
Sponsor:
The Netherlands Cancer Institute
Organization:
The Netherlands Cancer Institute
Organization Data
Organization:
The Netherlands Cancer Institute
Class:
OTHER
Study ID:
N22CLB
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The Netherlands Cancer Institute
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None